{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:22:28Z","timestamp":1783635748215,"version":"3.55.0"},"publisher-location":"New York, NY","reference-count":85,"publisher":"Springer US","isbn-type":[{"value":"9781071650493","type":"print"},{"value":"9781071650509","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5050-9_4","type":"book-chapter","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:05:14Z","timestamp":1783634714000},"page":"37-55","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Detection of Circulating Tumor Cells with an Epithelial-to-Mesenchymal Transition Phenotype"],"prefix":"10.1007","author":[{"given":"Dominika \u0160mi\u010dkov\u00e1","family":"Rusn\u00e1kov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Tom\u00e1\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pin\u010f\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Mego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"4_CR2","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S0140-6736(16)31392-7","volume":"389","author":"O Ginsburg","year":"2017","unstructured":"Ginsburg O, Bray F, Coleman MP et al (2017) The global burden of women\u2019s cancers: a grand challenge in global health. Lancet 389:847\u2013860. https:\/\/doi.org\/10.1016\/S0140-6736(16)31392-7","journal-title":"Lancet"},{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3322\/caac.21320","volume":"66","author":"CE DeSantis","year":"2016","unstructured":"DeSantis CE, Fedewa SA, Goding Sauer A et al (2016) Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin 66:31\u201342. https:\/\/doi.org\/10.3322\/caac.21320","journal-title":"CA Cancer J Clin"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67:7\u201330. https:\/\/doi.org\/10.3322\/caac.21387","journal-title":"CA Cancer J Clin"},{"key":"4_CR5","doi-asserted-by":"publisher","unstructured":"Hall C, Valad L, Lucci A (2016) Circulating tumor cells in breast cancer patients. Crit Rev Oncog 21(1-2):125-139. https:\/\/doi.org\/10.1615\/CritRevOncog.2016016120. PMID: 27481009","DOI":"10.1615\/CritRevOncog.2016016120"},{"key":"4_CR6","doi-asserted-by":"publisher","first-page":"10.","DOI":"10.3892\/ol.2024.14756","volume":"29","author":"D \u0160mi\u010dkov\u00e1 Rusn\u00e1kov\u00e1","year":"2025","unstructured":"Rusn\u00e1kov\u00e1 D \u0160mi\u010dkov\u00e1, Aziri R, Dubovan\u00a0P et al (2025) Detection, significance and potential utility of circulating tumor cells in clinical practice in breast cancer (Review). Oncol Lett 29:10. https:\/\/doi.org\/10.3892\/ol.2024.14756","journal-title":"Oncol Lett"},{"key":"4_CR7","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1038\/sj.bjc.6605071","volume":"100","author":"H Enderling","year":"2009","unstructured":"Enderling H, Hlatky L, Hahnfeldt P (2009) Migration rules: tumours are conglomerates of self-metastases. Br J Cancer 100:1917\u20131925. https:\/\/doi.org\/10.1038\/sj.bjc.6605071","journal-title":"Br J Cancer"},{"key":"4_CR8","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.cell.2009.11.025","volume":"139","author":"M-Y Kim","year":"2009","unstructured":"Kim M-Y, Oskarsson T, Acharyya S et al (2009) Tumor self-seeding by circulating cancer cells. Cell 139:1315\u20131326. https:\/\/doi.org\/10.1016\/j.cell.2009.11.025","journal-title":"Cell"},{"key":"4_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/emmm.201303698","volume":"7","author":"SA Joosse","year":"2015","unstructured":"Joosse SA, Gorges TM, Pantel K (2015) Biology, detection, and clinical implications of circulating tumor cells. EMBO Mol Med 7:1\u201311. https:\/\/doi.org\/10.15252\/emmm.201303698","journal-title":"EMBO Mol Med"},{"key":"4_CR10","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/onc.2015.192","volume":"35","author":"K Pantel","year":"2016","unstructured":"Pantel K, Speicher MR (2016) The biology of circulating tumor cells. Oncogene 35:1216\u20131224. https:\/\/doi.org\/10.1038\/onc.2015.192","journal-title":"Oncogene"},{"key":"4_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1373\/clinchem.2012.194258","volume":"59","author":"C Alix-Panabi\u00e8res","year":"2013","unstructured":"Alix-Panabi\u00e8res C, Pantel K (2013) Circulating tumor cells: liquid biopsy of cancer. Clin Chem 59:110\u2013118. https:\/\/doi.org\/10.1373\/clinchem.2012.194258","journal-title":"Clin Chem"},{"key":"4_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan S, Weinberg RA (2011) Tumor metastasis: molecular insights and evolving paradigms. Cell 147:275\u2013292. https:\/\/doi.org\/10.1016\/j.cell.2011.09.024","journal-title":"Cell"},{"key":"4_CR13","doi-asserted-by":"publisher","unstructured":"Jin X, Mu P (2015) Targeting breast cancer metastasis. Breast Cancer (Auckl) 9s1:BCBCR.S25460. https:\/\/doi.org\/10.4137\/BCBCR.S25460","DOI":"10.4137\/BCBCR.S25460"},{"key":"4_CR14","unstructured":"Weiss L (2000) Metastasis of cancer: a conceptual history from Antiquity to the 1990\u2019s. Leonard Weiss, Williamsville, NY"},{"key":"4_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000086626","volume":"69","author":"C Wittekind","year":"2005","unstructured":"Wittekind C, Neid M (2005) Cancer invasion and metastasis. Oncology 69:14\u201316. https:\/\/doi.org\/10.1159\/000086626","journal-title":"Oncology"},{"key":"4_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/1878-0261.12017","volume":"11","author":"KT Yeung","year":"2017","unstructured":"Yeung KT, Yang J (2017) Epithelial\u2013mesenchymal transition in tumor metastasis. Mol Oncol 11:28\u201339. https:\/\/doi.org\/10.1002\/1878-0261.12017","journal-title":"Mol Oncol"},{"key":"4_CR17","doi-asserted-by":"publisher","unstructured":"Kim DH, Xing T, Yang Z, et al (2018) Epithelial mesenchymal transition in embryonic development, tissue repair and cancer: a comprehensive overview. J Clin Med 7. https:\/\/doi.org\/10.3390\/jcm7010001","DOI":"10.3390\/jcm7010001"},{"key":"4_CR18","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1172\/JCI36183","volume":"119","author":"M Zeisberg","year":"2009","unstructured":"Zeisberg M, Neilson EG (2009) Biomarkers for epithelial-mesenchymal transitions. J Clin Investig 119:1429\u20131437","journal-title":"J Clin Investig"},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"1234850.","DOI":"10.1126\/science.1234850","volume":"342","author":"MA Nieto","year":"2013","unstructured":"Nieto MA (2013) Epithelial plasticity: a common theme in embryonic and cancer cells. Science 342:1234850. https:\/\/doi.org\/10.1126\/science.1234850","journal-title":"Science"},{"key":"4_CR20","doi-asserted-by":"publisher","unstructured":"Georgakopoulos-Soares I, Chartoumpekis DV, Kyriazopoulou V, Zaravinos A (2020) EMT factors and metabolic pathways in cancer. Front Oncol 10:499. https:\/\/doi.org\/10.3389\/fonc.2020.00499. PMID: 32318352; PMCID: PMC7154126.","DOI":"10.3389\/fonc.2020.00499"},{"key":"4_CR21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/CCO.0b013e32835b6371","volume":"25","author":"Y Katsuno","year":"2013","unstructured":"Katsuno Y, Lamouille S, Derynck R (2013) TGF-\u03b2 signaling and epithelial\u2013mesenchymal transition in cancer progression. Curr Opin Oncol 25:76\u201384","journal-title":"Curr Opin Oncol"},{"key":"4_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RY-J, Jackson RA, Thiery JP (2016) EMT: 2016. Cell 166:21\u201345. https:\/\/doi.org\/10.1016\/j.cell.2016.06.028","journal-title":"Cell"},{"key":"4_CR23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1146\/annurev-cellbio-092910-154036","volume":"27","author":"MA Nieto","year":"2011","unstructured":"Nieto MA (2011) The Ins and Outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol 27:347\u2013376","journal-title":"Annu Rev Cell Dev Biol"},{"key":"4_CR24","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nature05766","volume":"447","author":"M Ito","year":"2007","unstructured":"Ito M, Yang Z, Andl T et al (2007) Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding. Nature 447:316\u2013320. https:\/\/doi.org\/10.1038\/nature05766","journal-title":"Nature"},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ccr.2009.03.016","volume":"15","author":"Y Wu","year":"2009","unstructured":"Wu Y, Deng J, Rychahou PG et al (2009) Stabilization of snail by NF-\u03baB is required for inflammation-induced cell migration and invasion. Cancer Cell 15:416\u2013428","journal-title":"Cancer Cell"},{"key":"4_CR26","doi-asserted-by":"publisher","first-page":"9066","DOI":"10.1158\/0008-5472.CAN-07-0575","volume":"67","author":"H-W Lo","year":"2007","unstructured":"Lo H-W, Hsu S-C, Xia W et al (2007) Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res 67:9066\u20139076","journal-title":"Cancer Res"},{"key":"4_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ncb1691","volume":"10","author":"M-H Yang","year":"2008","unstructured":"Yang M-H, Wu M-Z, Chiou S-H et al (2008) Direct regulation of TWIST by HIF-1\u03b1 promotes metastasis. Nat Cell Biol 10:295\u2013305","journal-title":"Nat Cell Biol"},{"key":"4_CR28","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/ncb3157","volume":"17","author":"SC Wei","year":"2015","unstructured":"Wei SC, Fattet L, Tsai JH et al (2015) Matrix stiffness drives epithelial\u2013mesenchymal transition and tumour metastasis through a TWIST1\u2013G3BP2 mechanotransduction pathway. Nat Cell Biol 17:678\u2013688","journal-title":"Nat Cell Biol"},{"key":"4_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-1119(00)00371-1","volume":"257","author":"K Hemavathy","year":"2000","unstructured":"Hemavathy K, Ashraf SI, Ip YT (2000) Snail\/Slug family of repressors: slowly going into the fast lane of development and cancer. Gene 257:1\u201312. https:\/\/doi.org\/10.1016\/S0378-1119(00)00371-1","journal-title":"Gene"},{"key":"4_CR30","doi-asserted-by":"publisher","first-page":"e92254.","DOI":"10.1371\/journal.pone.0092254","volume":"9","author":"B Gras","year":"2014","unstructured":"Gras B, Jacqueroud L, Wierinckx A et al (2014) Snail family members unequally trigger EMT and thereby differ in their ability to promote the neoplastic transformation of mammary epithelial cells. PLoS ONE 9:e92254. https:\/\/doi.org\/10.1371\/journal.pone.0092254","journal-title":"PLoS ONE"},{"key":"4_CR31","doi-asserted-by":"publisher","unstructured":"Wang SS, Jiang J, Liang XH, Tang YL (2015) Links between cancer stem cells and epithelial-mesenchymal transition. Onco Targets Ther 8:2973-2980. https:\/\/doi.org\/10.2147\/OTT.S91863. PMID: 26527883; PMCID: PMC4621173","DOI":"10.2147\/OTT.S91863"},{"key":"4_CR32","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.1158\/0008-5472.CAN-05-3850","volume":"66","author":"J Yang","year":"2006","unstructured":"Yang J, Mani SA, Weinberg RA (2006) Exploring a new twist on tumor metastasis. Cancer Res 66:4549\u20134552. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-3850","journal-title":"Cancer Res"},{"key":"4_CR33","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1158\/0008-5472.CAN-10-2914","volume":"71","author":"J Hong","year":"2011","unstructured":"Hong J, Zhou J, Fu J et al (2011) Phosphorylation of Serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness. Cancer Res 71:3980\u20133990. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2914","journal-title":"Cancer Res"},{"key":"4_CR34","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1007\/s00018-012-0935-3","volume":"69","author":"A Gheldof","year":"2012","unstructured":"Gheldof A, Hulpiau P, Van Roy F et al (2012) Evolutionary functional analysis and molecular regulation of the ZEB transcription factors. Cell Mol Life Sci 69:2527\u20132541","journal-title":"Cell Mol Life Sci"},{"key":"4_CR35","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1038\/sj.onc.1208429","volume":"24","author":"A Eger","year":"2005","unstructured":"Eger A, Aigner K, Sonderegger S et al (2005) DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 24:2375\u20132385","journal-title":"Oncogene"},{"key":"4_CR36","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/15384101.2015.1006048","volume":"14","author":"P Zhang","year":"2015","unstructured":"Zhang P, Sun Y, Ma L (2015) ZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance. Cell Cycle 14:481\u2013487","journal-title":"Cell Cycle"},{"key":"4_CR37","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1083\/jcb.200506094","volume":"171","author":"Y Qin","year":"2005","unstructured":"Qin Y, Capaldo C, Gumbiner BM, Macara IG (2005) The mammalian Scribble polarity protein regulates epithelial cell adhesion and migration through E-cadherin. J Cell Biol 171:1061\u20131071","journal-title":"J Cell Biol"},{"key":"4_CR38","doi-asserted-by":"publisher","first-page":"e23899","DOI":"10.1371\/journal.pone.0023899","volume":"6","author":"S Howard","year":"2011","unstructured":"Howard S, Deroo T, Fujita Y, Itasaki N (2011) A positive role of cadherin in Wnt\/\u03b2-catenin signalling during epithelial-mesenchymal transition. PLoS ONE 6:e23899","journal-title":"PLoS ONE"},{"key":"4_CR39","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ejcb.2014.07.003","volume":"93","author":"BT Beaty","year":"2014","unstructured":"Beaty BT, Condeelis J (2014) Digging a little deeper: the stages of invadopodium formation and maturation. Eur J Cell Biol 93:438\u2013444","journal-title":"Eur J Cell Biol"},{"key":"4_CR40","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.celrep.2014.07.050","volume":"8","author":"HS Leong","year":"2014","unstructured":"Leong HS, Robertson AE, Stoletov K et al (2014) Invadopodia are required for cancer cell extravasation and are a therapeutic target for metastasis. Cell Rep 8:1558\u20131570","journal-title":"Cell Rep"},{"key":"4_CR41","doi-asserted-by":"publisher","first-page":"e2254","DOI":"10.1038\/cddis.2016.149","volume":"7","author":"Q Xu","year":"2016","unstructured":"Xu Q, Deng F, Qin Y et al (2016) Long non-coding RNA regulation of epithelial\u2013mesenchymal transition in cancer metastasis. Cell Death Dis 7:e2254\u2013e2254","journal-title":"Cell Death Dis"},{"key":"4_CR42","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41392-020-00313-5","volume":"5","author":"S Qin","year":"2020","unstructured":"Qin S, Jiang J, Lu Y et al (2020) Emerging role\u00a0of\u00a0tumor cell plasticity in modifying therapeutic response. Signal Transduct Target Ther 5:228. https:\/\/doi.org\/10.1038\/s41392-020-00313-5","journal-title":"Signal Transduct Target Ther"},{"key":"4_CR43","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1126\/science.1228522","volume":"339","author":"M Yu","year":"2013","unstructured":"Yu M, Bardia A, Wittner BS et al (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339:580\u2013584. https:\/\/doi.org\/10.1126\/science.1228522","journal-title":"Science"},{"key":"4_CR44","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1186\/bcr3099","volume":"14","author":"S Kasimir-Bauer","year":"2012","unstructured":"Kasimir-Bauer S, Hoffmann O, Wallwiener D et al (2012) Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells. Breast Cancer Res 14:R15. https:\/\/doi.org\/10.1186\/bcr3099","journal-title":"Breast Cancer Res"},{"key":"4_CR45","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1158\/1535-7163.MCT-12-0460","volume":"11","author":"A Giordano","year":"2012","unstructured":"Giordano A, Gao H, Anfossi S et al (2012) Epithelial\u2013mesenchymal transition and stem cell markers in patientswith HER2-positive metastatic breast cancer. Mol Cancer Ther 11:2526\u20132534. https:\/\/doi.org\/10.1158\/1535-7163.MCT-12-0460","journal-title":"Mol Cancer Ther"},{"key":"4_CR46","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/ijc.26037","volume":"130","author":"M Mego","year":"2012","unstructured":"Mego M, Mani SA, Lee B-N et al (2012) Expression of epithelial\u2013mesenchymal transition-inducing transcription factors in primary breast cancer: the effect of neoadjuvant therapy. Int J Cancer 130:808\u2013816. https:\/\/doi.org\/10.1002\/ijc.26037","journal-title":"Int J Cancer"},{"key":"4_CR47","doi-asserted-by":"publisher","first-page":"R46","DOI":"10.1186\/bcr2333","volume":"11","author":"B Aktas","year":"2009","unstructured":"Aktas B, Tewes M, Fehm T et al (2009) Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res 11:R46. https:\/\/doi.org\/10.1186\/bcr2333","journal-title":"Breast Cancer Res"},{"key":"4_CR48","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/bcr2149","volume":"10","author":"G Kallergi","year":"2008","unstructured":"Kallergi G, Agelaki S, Kalykaki A et al (2008) Phosphorylated EGFR and PI3K\/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients. Breast Cancer Res 10:R80. https:\/\/doi.org\/10.1186\/bcr2149","journal-title":"Breast Cancer Res"},{"key":"4_CR49","doi-asserted-by":"publisher","first-page":"R84","DOI":"10.1186\/bcr2452","volume":"11","author":"G Kallergi","year":"2009","unstructured":"Kallergi G, Markomanolaki H, Giannoukaraki V et al (2009) Hypoxia-inducible factor-1\u03b1 and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients. Breast Cancer Res 11:R84. https:\/\/doi.org\/10.1186\/bcr2452","journal-title":"Breast Cancer Res"},{"key":"4_CR50","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10549-009-0461-7","volume":"118","author":"M Pestrin","year":"2009","unstructured":"Pestrin M, Bessi S, Galardi F et al (2009) Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients. Breast Cancer Res Treat 118:523\u2013530. https:\/\/doi.org\/10.1007\/s10549-009-0461-7","journal-title":"Breast Cancer Res Treat"},{"key":"4_CR51","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1186\/s12885-015-1548-7","volume":"15","author":"M Mego","year":"2015","unstructured":"Mego M, Cierna Z, Janega P et al (2015) Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer. BMC Cancer 15:533. https:\/\/doi.org\/10.1186\/s12885-015-1548-7","journal-title":"BMC Cancer"},{"key":"4_CR52","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/1471-2407-14-472","volume":"14","author":"Z Cierna","year":"2014","unstructured":"Cierna Z, Mego M, Janega P et al (2014) Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer. BMC Cancer 14:472. https:\/\/doi.org\/10.1186\/1471-2407-14-472","journal-title":"BMC Cancer"},{"key":"4_CR53","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.21873\/anticanres.13290","volume":"39","author":"M Mego","year":"2019","unstructured":"Mego M, Karaba M, Minarik G et al (2019) Circulating tumor cells with epithelial\u2013to\u2013mesenchymal transition phenotypes associated with inferior outcomes in primary breast cancer. Anticancer Res 39:1829. https:\/\/doi.org\/10.21873\/anticanres.13290","journal-title":"Anticancer Res"},{"key":"4_CR54","doi-asserted-by":"publisher","first-page":"59.","DOI":"10.3390\/cancers11010059","volume":"11","author":"A Markiewicz","year":"2019","unstructured":"Markiewicz A, Topa J, Nagel A et al (2019) Spectrum of epithelial-mesenchymal transition phenotypes in circulating tumour cells from early breast cancer patients. Cancers 11:59. https:\/\/doi.org\/10.3390\/cancers11010059","journal-title":"Cancers"},{"key":"4_CR55","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13058-016-0687-3","volume":"18","author":"M Bulfoni","year":"2016","unstructured":"Bulfoni M, Gerratana L, Del Ben F et al (2016) In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis. Breast Cancer Res 18:30. https:\/\/doi.org\/10.1186\/s13058-016-0687-3","journal-title":"Breast Cancer Res"},{"key":"4_CR56","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/dvdy.24506","volume":"247","author":"M-E Francart","year":"2018","unstructured":"Francart M-E, Lambert J, Vanwynsberghe AM et al (2018) Epithelial\u2013mesenchymal plasticity and circulating tumor cells: travel companions to metastases. Developmental Dyn 247:432\u2013450. https:\/\/doi.org\/10.1002\/dvdy.24506","journal-title":"Developmental Dyn"},{"key":"4_CR58","doi-asserted-by":"publisher","first-page":"7135","DOI":"10.1158\/0008-5472.CAN-09-1618","volume":"69","author":"T Tsuji","year":"2009","unstructured":"Tsuji T, Ibaragi S, Hu G (2009) Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res 69:7135\u20137139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1618","journal-title":"Cancer Res"},{"key":"4_CR57","doi-asserted-by":"publisher","unstructured":"Jolly MK, Boareto M, Huang B, Jia D, Lu M, Ben-Jacob E, Onuchic JN, Levine H (2015) Implications of the hybrid epithelial\/mesenchymal phenotype in metastasis. Front Oncol 5:155. https:\/\/doi.org\/10.3389\/fonc.2015.00155. PMID: 26258068; PMCID: PMC4507461","DOI":"10.3389\/fonc.2015.00155"},{"key":"4_CR59","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1158\/0008-5472.CAN-12-0326","volume":"73","author":"T Yokobori","year":"2013","unstructured":"Yokobori T, Iinuma H, Shimamura T et al (2013) Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial\u2013mesenchymal transition and is associated with colorectal cancer prognosis. Cancer Res 73:2059\u20132069. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-0326","journal-title":"Cancer Res"},{"key":"4_CR60","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/bjc.2015.132","volume":"112","author":"H Ueo","year":"2015","unstructured":"Ueo H, Sugimachi K, Gorges TM et al (2015) Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer. Br J Cancer 112:1519\u20131526. https:\/\/doi.org\/10.1038\/bjc.2015.132","journal-title":"Br J Cancer"},{"key":"4_CR61","doi-asserted-by":"publisher","unstructured":"Zhao Q, Li B, Gao Q, Luo Y, Ming L (2022) Prognostic value of epithelial-mesenchymal transition circulating tumor cells in female breast cancer: a meta-analysis. Front Oncol 12:1024783. https:\/\/doi.org\/10.3389\/fonc.2022.1024783. PMID: 36530995; PMCID: PMC9749886","DOI":"10.3389\/fonc.2022.1024783"},{"key":"4_CR62","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11684-018-0656-6","volume":"12","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Weinberg RA (2018) Epithelial-to-mesenchymal transition in cancer: complexity and opportunities. Front Med 12:361\u2013373. https:\/\/doi.org\/10.1007\/s11684-018-0656-6","journal-title":"Front Med"},{"key":"4_CR63","doi-asserted-by":"publisher","unstructured":"Tashireva LA, Savelieva OE, Grigoryeva ES, Nikitin YV, Denisov EV, Vtorushin SV, Zavyalova MV, Cherdyntseva NV, Perelmuter VM (2021) Heterogeneous manifestations of epithelial-mesenchymal plasticity of circulating tumor cells in breast cancer patients. Int J Mol Sci 22(5):2504. https:\/\/doi.org\/10.3390\/ijms22052504. PMID: 33801519; PMCID: PMC7958863","DOI":"10.3390\/ijms22052504"},{"key":"4_CR64","doi-asserted-by":"publisher","unstructured":"Strati A, Nikolaou M, Georgoulias V, Lianidou ES (2019) Prognostic significance of TWIST1, CD24, CD44, and ALDH1 transcript quantification in EpCAM-positive circulating tumor cells from early stage breast cancer patients. Cells 8(7):652. https:\/\/doi.org\/10.3390\/cells8070652. PMID: 31261917; PMCID: PMC6679222","DOI":"10.3390\/cells8070652"},{"key":"4_CR65","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1038\/onc.2011.483","volume":"31","author":"F Vesuna","year":"2012","unstructured":"Vesuna F, Lisok A, Kimble B et al (2012) Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-\u03b1. Oncogene 31:3223\u20133234. https:\/\/doi.org\/10.1038\/onc.2011.483","journal-title":"Oncogene"},{"key":"4_CR66","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1373\/clinchem.2014.228122","volume":"61","author":"A Satelli","year":"2015","unstructured":"Satelli A, Brownlee Z, Mitra A et al (2015) Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule\u2013 and cell-surface vimentin\u2013based methods for monitoring breast cancer therapeutic response. Clin Chem 61:259\u2013266. https:\/\/doi.org\/10.1373\/clinchem.2014.228122","journal-title":"Clin Chem"},{"key":"4_CR67","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1126\/science.1228522","volume":"339","author":"M Yu","year":"2013","unstructured":"Yu M, Bardia A, Wittner BS et al (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339:580\u2013584. https:\/\/doi.org\/10.1126\/science.1228522","journal-title":"Science"},{"key":"4_CR68","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2147\/CMAR.S149801","volume":"9","author":"S Zhang","year":"2017","unstructured":"Zhang S, Wu T, Peng X et al (2017) Mesenchymal phenotype of circulating tumor cells is associated with distant metastasis in breast cancer patients. Cancer Manag Res 9:691\u2013700. https:\/\/doi.org\/10.2147\/CMAR.S149801","journal-title":"Cancer Manag Res"},{"key":"4_CR69","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1007\/s10620-018-5124-2","volume":"63","author":"H Ou","year":"2018","unstructured":"Ou H, Huang Y, Xiang L et al (2018) Circulating tumor cell phenotype indicates poor survival and recurrence after surgery for hepatocellular carcinoma. Dig Dis Sci 63:2373\u20132380. https:\/\/doi.org\/10.1007\/s10620-018-5124-2","journal-title":"Dig Dis Sci"},{"key":"4_CR70","doi-asserted-by":"publisher","first-page":"369","DOI":"10.7150\/jca.5111","volume":"3","author":"M Mego","year":"2012","unstructured":"Mego M, Gao H, Lee B-N et al (2012) Prognostic value of EMT-circulating tumor cells in metastatic breast cancer patients undergoing high-dose chemotherapy with autologous hematopoietic stem cell transplantation. J Cancer 3:369\u2013380. https:\/\/doi.org\/10.7150\/jca.5111","journal-title":"J Cancer"},{"key":"4_CR71","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1158\/1535-7163.MCT-18-0584","volume":"18","author":"MA Papadaki","year":"2019","unstructured":"Papadaki MA, Stoupis G, Theodoropoulos PA et al (2019) Circulating tumor cells with stemness and epithelial-to-mesenchymal transition features are chemoresistant and predictive of poor outcome in metastatic breast cancer. Mol Cancer Therap 18:437\u2013447. https:\/\/doi.org\/10.1158\/1535-7163.MCT-18-0584","journal-title":"Mol Cancer Therap"},{"key":"4_CR72","doi-asserted-by":"publisher","unstructured":"Polioudaki H, Mala A, Gkimprixi E, Papadaki MA, Chantziou A, Tzardi M, Mavroudis D, Agelaki S, Theodoropoulos PA (2020) Epithelial\/mesenchymal characteristics and PD-L1 co-expression in CTCs of metastatic breast cancer patients treated with eribulin: correlation with clinical outcome. Cancers (Basel) 12(12):3735. https:\/\/doi.org\/10.3390\/cancers12123735. PMID: 33322610; PMCID: PMC7764288","DOI":"10.3390\/cancers12123735"},{"key":"4_CR73","unstructured":"ClinicalTrials.gov, Identifier: NCT05550415. Vimentin expression-based therapeutic response in triple negative breast cancer receiving combination of simvastatin and NAC: a randomized, double-blind, placebo-controlled trial. ClinicalTrials.gov 2022\u20132025. Available from https:\/\/clinicaltrials.gov\/study\/NCT05550415. Accessed December 27, 2025"},{"key":"4_CR74","unstructured":"ClinicalTrials.gov, Identifier: NCT04664829. The role of bexarotene in inducing susceptibility to chemotherapy in metastatic TNBC: a phase 1 study. ClinicalTrials.gov 2020\u2013. Available from https:\/\/clinicaltrials.gov\/study\/NCT04664829"},{"key":"4_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-018-1663-8","volume":"16","author":"Y Horimoto","year":"2018","unstructured":"Horimoto Y, Tokuda E, Murakami F et al (2018) Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study. J Transl Med 16:1\u20138","journal-title":"J Transl Med"},{"key":"4_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40880-018-0346-4","volume":"39","author":"X Guan","year":"2019","unstructured":"Guan X, Ma F, Li C et al (2019) The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial\u2013mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer. Cancer Commun 39:1\u201310","journal-title":"Cancer Commun"},{"key":"4_CR77","doi-asserted-by":"publisher","first-page":"e1044","DOI":"10.1634\/theoncologist.2018-0697","volume":"24","author":"W Tan","year":"2019","unstructured":"Tan W, Liang G, Xie X et al (2019) Incorporating MicroRNA into molecular phenotypes of circulating tumor cells enhances the prognostic accuracy for patients with metastatic breast cancer. Oncologist 24:e1044\u2013e1054","journal-title":"Oncologist"},{"key":"4_CR78","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.3390\/cancers12051134","volume":"12","author":"S Miklikova","year":"2020","unstructured":"Miklikova S, Minarik G, Sedlackova T et al (2020) Inflammation-based scores increase the prognostic value of circulating tumor cells in primary breast cancer. Cancers 12:1134","journal-title":"Cancers"},{"key":"4_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-020-02237-8","volume":"18","author":"J Chen","year":"2020","unstructured":"Chen J, Ye C, Dong J et al (2020) Metabolic classification of circulating tumor cells as a biomarker for metastasis and prognosis in breast cancer. J Transl Med 18:1\u201314","journal-title":"J Transl Med"},{"key":"4_CR80","doi-asserted-by":"publisher","first-page":"28910","DOI":"10.1038\/srep28910","volume":"6","author":"A Satelli","year":"2016","unstructured":"Satelli A, Batth IS, Brownlee Z et al (2016) Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients. Sci Rep 6:28910.","journal-title":"Sci Rep"},{"key":"4_CR81","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.biopha.2018.08.097","volume":"107","author":"D Mehlich","year":"2018","unstructured":"Mehlich D, Garbicz F, W\u0142odarski PK (2018) The emerging roles of the polycistronic miR-106b\u223c 25 cluster in cancer\u2014a comprehensive review. Biomed Pharmacother 107:1183\u20131195","journal-title":"Biomed Pharmacother"},{"key":"4_CR82","first-page":"138","volume":"39","author":"Y Qiu","year":"2018","unstructured":"Qiu Y, Liu Y, Li W-H et al (2018) P2Y2 receptor promotes the migration and invasion of breast cancer cells via EMT-related genes Snail and E-cadherin. Oncol Rep 39:138\u2013150","journal-title":"Oncol Rep"},{"key":"4_CR83","doi-asserted-by":"publisher","first-page":"602222","DOI":"10.3389\/fonc.2021.602222","volume":"11","author":"X Guan","year":"2021","unstructured":"Guan X, Li C, Li Y et al (2021) Epithelial-mesenchymal-transition-like circulating tumor cell-associated white blood cell clusters as a prognostic biomarker in HR-positive\/HER2-negative metastatic breast cancer. Front Oncol 11:602222","journal-title":"Front Oncol"},{"key":"4_CR84","doi-asserted-by":"publisher","first-page":"6067","DOI":"10.1158\/0008-5472.CAN-19-1972","volume":"79","author":"M Saini","year":"2019","unstructured":"Saini M, Szczerba BM, Aceto N (2019) Circulating tumor cell-neutrophil tango along the metastatic process. Cancer Res 79:6067\u20136073","journal-title":"Cancer Res"},{"key":"4_CR85","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.semcancer.2019.10.008","volume":"60","author":"C Reduzzi","year":"2020","unstructured":"Reduzzi C, Vismara M, Gerratana L et al (2020) The curious phenomenon of dual-positive circulating cells: longtime overlooked tumor cells. Semin Cancer Biol 60:344\u2013350.","journal-title":"Semin Cancer Biol"}],"container-title":["Methods in Molecular Biology","Circulating Tumor Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5050-9_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:05:15Z","timestamp":1783634715000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5050-9_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071650493","9781071650509"],"references-count":85,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5050-9_4","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"3 June 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}